- Home
- MOVE vs IBIO Comparison
MOVE vs IBIO Comparison
Compare MOVE & IBIO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MOVE
- IBIO
- Stock Information
- Founded
- MOVE 2018
- IBIO 2008
- Country
- MOVE United States
- IBIO United States
- Employees
- MOVE N/A
- IBIO N/A
- Industry
- MOVE Biotechnology: Electromedical & Electrotherapeutic Apparatus
- IBIO Biotechnology: Pharmaceutical Preparations
- Sector
- MOVE Health Care
- IBIO Health Care
- Exchange
- MOVE Nasdaq
- IBIO Nasdaq
- Market Cap
- MOVE 25.9M
- IBIO 24.3M
- IPO Year
- MOVE 2021
- IBIO N/A
- Fundamental
- Price
- MOVE $5.98
- IBIO $2.41
- Analyst Decision
- MOVE Buy
- IBIO Strong Buy
- Analyst Count
- MOVE 1
- IBIO 3
- Target Price
- MOVE $30.00
- IBIO $4.87
- AVG Volume (30 Days)
- MOVE 84.2K
- IBIO 98.8K
- Earning Date
- MOVE 11-14-2024
- IBIO 02-07-2025
- Dividend Yield
- MOVE N/A
- IBIO N/A
- EPS Growth
- MOVE N/A
- IBIO N/A
- EPS
- MOVE N/A
- IBIO N/A
- Revenue
- MOVE $902,000.00
- IBIO $175,000.00
- Revenue This Year
- MOVE N/A
- IBIO N/A
- Revenue Next Year
- MOVE $545.31
- IBIO N/A
- P/E Ratio
- MOVE N/A
- IBIO N/A
- Revenue Growth
- MOVE N/A
- IBIO 250.00
- 52 Week Low
- MOVE $2.80
- IBIO $1.02
- 52 Week High
- MOVE $12.75
- IBIO $4.98
- Technical
- Relative Strength Index (RSI)
- MOVE 60.59
- IBIO 45.02
- Support Level
- MOVE $5.75
- IBIO $2.24
- Resistance Level
- MOVE $6.97
- IBIO $2.75
- Average True Range (ATR)
- MOVE 0.52
- IBIO 0.23
- MACD
- MOVE 0.05
- IBIO -0.03
- Stochastic Oscillator
- MOVE 54.36
- IBIO 23.29
About MOVE Movano Inc.
Movano Inc is developing a platform to deliver purpose-driven healthcare solutions to bring medical-grade, high-quality data to the forefront of consumer health devices. its initial commercial product in development is the Evie Ring, a wearable designed specifically for women. The Evie Ring combines health and wellness metrics to give a full picture of one's health, which includes resting heart rate, heart rate variability (HRV), blood oxygen saturation (SpO2), respiration rate, skin temperature variability, period and ovulation tracking, menstrual symptom tracking, activity profile, including steps, active minutes and calories burned, sleep stages and duration, and mood tracking.
About IBIO iBio Inc.
iBio Inc is a preclinical stage biotechnology company that leverages the power of Artificial Intelligence (AI) for the development of precision antibodies. CDMO. Its technology stack is designed to minimize downstream development risks by employing AI-guided epitope-steering and monoclonal antibody (mAb) optimization.